New CAR-T therapy aims to remove transplant barriers in blood disease patients
Disease control
Not yet recruiting
This early-stage study tests a new treatment using special immune cells (CAR-T cells) designed to target and reduce harmful antibodies that can prevent a successful stem cell transplant. The study involves up to 18 people with blood diseases who have these antibodies. The goal is…
Phase: PHASE1, PHASE2 • Sponsor: Chang Yingjun • Aim: Disease control
Last updated May 04, 2026 16:22 UTC